-
Hydroxychloroquine for coronavirus shows no benefit, possible harm in study awaiting validation
expresspharma
April 23, 2020
An analysis of Veterans Health Administration (VA) data found that 28 per cent of 97 patients given hydroxychloroquine along with standard care died, compared with a death rate of 11 per cent for the 158 patients that did not receive the drug.
-
Indian pharmaceutical firms will play important role in fight against COVID19 pandemic: Ambassador Taranjit Singh Sandhu
expresspharma
April 23, 2020
India, one of the largest producers of anti-malarial drug hydroxychloroquine, has seen a spurt in demand in recent weeks. India has sent the drug to over 50 countries over the last few days, including the United States, he said.
-
Rutgers Coronavirus Saliva Test Receives FDA Approval
americanpharmaceuticalreview
April 21, 2020
The Food and Drug Administration (FDA) has granted emergency use authorization (EUA) to Rutgers’ RUCDR Infinite Biologics and its collaborators for a new collection approach that utilizes saliva as the primary test biomaterial for the SARS-CoV-2 coronavir
-
Gilead’s remdesivir prevents Covid-19 progression in preclinical study
pharmaceutical-technology
April 21, 2020
A preclinical study in the US found that Gilead Sciences’ antiviral drug candidate remdesivir prevented disease progression in rhesus macaques monkeys with Covid-19.
-
Wavelength Ups API Production for Essential Respiratory Meds
contractpharma
April 21, 2020
Products in demand due to coronavirus pandemic include Midazolam, Cisatracurium, and Rocuronium.
-
Clinical trials on zinc usage initiated for treatment of patients with severe symptoms of COVID-19
expresspharma
April 21, 2020
Zinc is proven to be effective at slowing the rate that similar viruses such as SARS and common cold replicate in the body.
-
Government to extend coronavirus testing
pharmatimes
April 20, 2020
As of this morning – Monday April 20 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 120,067 with 16,060 deaths.
-
Quansys Biosciences Releases Multiplex Human Serological SARS-CoV-2
americanpharmaceuticalreview
April 20, 2020
Quansys Biosciences has released their SARS-CoV-2 Human IgG(4-plex) enzyme-linked immunosorbent assay (ELISA) for the qualitative detection of SARS-CoV-2 reactive IgG class antibodies in human serum and plasma.
-
Chandigarh-based IMTech to begin genome sequencing of novel coronavirus
expresspharma
April 20, 2020
The genomic resource obtained from this sequencing will also allow identification of new targets of diagnosis and drugs for COVID-19.
-
Institutional investors tell Big Pharma to cooperate on coronavirus
expresspharma
April 20, 2020
The investor group plan to send pharma companies a list of principles it wants them to abide by for the coming year.